Philips Spotlights Latest AI-Powered, Software-Defined MR Smart Systems at ECR 2022

With personalized treatment for complex diseases such as cancer increasing the need for high-confidence precision diagnoses, coupled with soaring caseloads due to aging populations and high levels of clinician burnout, radiology departments are under increasing pressure to improve performance, productivity, and profitability. Philips SmartSpeed, the latest addition to the company’s expanding portfolio of AI-driven, smart, connected imaging and smart workflow solutions, helps achieve the Quadruple Aim of improving diagnostic outcomes, enhancing patient and staff experiences, and reducing overall healthcare costs. Adding advanced AI data collection algorithms to Philips’ existing Compressed SENSE MR acceleration engine, Philips SmartSpeed delivers higher image resolution with three times faster scan times and virtually no loss in image quality, representing a major step forward in diagnostic confidence and MR department productivity.

The latest AI-powered MR software increases resolution up to 65% and achieves up to three times faster scanning times compared to conventional MR scans. Coupled with its support for 97% of current clinical protocols – including advanced contrasts and diffusion weighted imaging, and even quantitative imaging such at T1 or T2 mapping for brain, liver, heart or musculoskeletal (MSK) imaging – Philips SmartSpeed helps increase diagnostic confidence in a wide range of patients, including the most complex cases. Its unique deep learning technology is applied at the source of the MR signal and seamlessly integrated with Philips leading Compressed SENSE speed engine to deliver higher resolution and high signal-to-noise ratio needed for detailed images, small lesion detection and enhanced diagnosis. Philips SmartSpeed uses an award-winning AI reconstruction algorithm at the front-end of the MR signal to remove noise and preserve details while enabling k-space data consistency check for trustworthy AI.

At ECR 2022, Philips also showcased its smart connected 3T MR system, Philips MR 7700 that was recently introduced in Europe and the company’s latest MR 5300 1.5T helium-free in operations MR system. The new, FDA-cleared MR 7700 3.0T MR system is the latest break-through MR innovation from Philips that delivers unmatched performance and precision for both research and advanced clinical diagnostics. The XP gradients of MR 7700 provide high accuracy to support a confident diagnosis for every patient with Philips’ highest quality diffusion imaging and advanced neuroscience, supporting improved patient care and lower costs. Also on display was the FDA-cleared MR 5300 system, the company’s latest BlueSeal fully-sealed helium-free in operations MR scanner that is powered by AI, and simplifies and automates complex clinical and operational tasks for outpatient clinical use and MR departments to help increase access to affordable, quality care.

“By taking the Quadruple Aim as a starting point to develop and deploy AI solutions, we have a tremendous opportunity to address the inefficiencies and growing demand that our customers and partners face every day,” said Kees Wesdorp, Chief Business Leader of Precision Diagnosis at Philips. “Powered by AI, our ​leading technologies and smart connected imaging solutions help turn data into actionable insights to increase diagnostic confidence and help improve clinical outcomes for patients.’’

Related Links:
Royal Philips